Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 4Oligodendroglioma 3Gliosarcoma 3Glioma 3Brain Neoplasms 3Astrocytoma 3Central Nervous System Neoplasms 2Supratentorial Neoplasms 1Spinal Cord Neoplasms 1Rhabdoid Tumor 1Optic Nerve Glioma 1Medulloblastoma 1Glioma, Subependymal 1Familial ependymoma 1Ependymoma 1Choroid Plexus Neoplasms 1

Interventions

Filgrastim 13Temozolomide 9Carboplatin 7Peripheral Blood Stem Cell Transplantation 6Cyclophosphamide 5sargramostim 4Magnetic Resonance Spectroscopy 4Irinotecan 4Etoposide 4Topotecan 3Thiotepa 3Radiotherapy 3Oxaliplatin 3O(6)-benzylguanine 3Granulocyte Colony-Stimulating Factor 3Busulfan 3etoposide phosphate 2Vorinostat 2Vincristine 2Specimen Handling 2Psychiatric Rehabilitation 2Melphalan 2Ifosfamide 2Erlotinib Hydrochloride 2Cyproheptadine 2Cisplatin 2Carmustine 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2veliparib 1trioctyl phosphine oxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Familial ependymoma × lonafarnib × CNS × Clear all
NCT00015899 2009-10-14

SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors

Pediatric Brain Tumor Consortium

Phase 1 Completed
53 enrolled
CNS

Familial ependymoma, Astrocytoma, Medulloblastoma, Oligodendroglioma, Spinal Cord Neoplasms, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Rhabdoid Tumor, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡